MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-WB-10-0010432
Southend Pharma Pvt Ltd
Southend Pharma Pvt Ltd - pharma in Kolkata, West Bengal, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹21.94 Cr
▼ 25% YoY
Net profit · FY 2025
₹24.84 Lakh
Net margin 1.1%
EBITDA · FY 2025
₹87.01 Lakh
EBITDA margin 4%
Authorised capital
₹75 Lakh
Registered with MCA
Paid-up capital
₹49.85 Lakh
Issued & subscribed
Open charges
₹1.4 Cr
Secured borrowings
Company age
37 yrs
Est. 1989
Directors on board
9
As per MCA filings
About Southend Pharma Pvt Ltd
Data last updated:
Southend Pharma Pvt Ltd is a private limited company based in Kolkata, West Bengal, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 28 April 1989 and has been in existence for over 37 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U51909WB1989PTC046785. Its GSTIN is 19AADCS6110P1Z0 (West Bengal).
The company has an authorised share capital of ₹75 Lakh and a paid-up capital of ₹49.85 Lakh. It is led by directors including Ajoy Kumar Lohia and Sanjoy Kumar Lohia.
Its last annual general meeting (AGM) was held on 27 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Kolkata, West Bengal.
As per the financials filed for FY 2025, the company reported a revenue of ₹21.94 Cr, a decline of 25% compared to the previous year. For the same year it recorded a net profit of ₹24.84 Lakh (net margin 1.1%) and EBITDA of ₹87.01 Lakh (EBITDA margin 4%). Revenue has grown at a compounded annual rate (CAGR) of 5% over three years and 10% over five years.
As per MCA filings, the company has open charges of ₹1.4 Cr on record.
Southend Pharma Pvt Ltd is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-WB-10-0010432). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U51909WB1989PTC046785
Registration Number 046785
Incorporation Date 28 April 1989
ROC Kolkata
Listing Status Unlisted
Company Status Active
Date of Last AGM 27 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-WB-10-0010432
Recognitions & Rankings of Southend Pharma
Contact details
Southend Pharma Pvt Ltd's registered office is in Kolkata, West Bengal. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressGround Floor Taranya House, 80B Swami Swarupananda Sarni, Kolkata, West Bengal, India – 700054
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Southend Pharma Pvt Ltd, buy the company report.
Comprehensive company report
Southend Pharma Pvt Ltd - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Southend Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Southend Pharma Pvt Ltd, buy the company report.
Financials of Southend Pharma Pvt Ltd
FY 2025 filings availableSouthend Pharma Pvt Ltd reported revenue of ₹21.94 Cr (down 25% YoY) for FY 2025.
Revenue · FY 2025
₹21.94 Cr ▼ 25%
Net profit · FY 2025
₹24.84 Lakh margin 1.1%
EBITDA · FY 2025
₹87.01 Lakh margin 4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 25%
3 years · compounded
▼ 5%
5 years · compounded
▲ 10%
EBITDA CAGR growth
1 year
▼ 19%
3 years · compounded
▼ 5%
5 years · compounded
▲ 11%
Revenue fell 25% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 10%. EBITDA fell 19% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹87.01 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹24.84 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4% | ||||
| Net Profit Margin | 1.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Southend Pharma Pvt Ltd, buy the company report.
Board of directors of Southend Pharma Pvt Ltd
Southend Pharma has 9 current directors and 11 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ajoy Kumar Lohia Also directs: Evans Medica Private Limited | Director | 28 Apr 1989 | 37 Years 5 Months | Current |
| Sanjoy Kumar Lohia | Director | 28 Apr 1989 | 37 Years 5 Months | Current |
| Surendra Dhanuka Also directs: Club View Villa LLP, Stardm Meditech Private Limited | Director | 24 Aug 2009 | 17 Years 2 Months | Current |
| Sandhya Lohia | Director | 14 Feb 2020 | 6 Years 8 Months | Current |
| Ankit Lohia Also directs: Evans Medica Private Limited | Director | 03 Dec 2018 | 7 Years 10 Months | Current |
| Saket Lohia | Director | 03 Dec 2018 | 7 Years 10 Months | Current |
Showing 6 of 9 current directors. View all directors
Peer comparison
Southend Pharma Pvt Ltd is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Medibox Pharma Private Limited | ₹22.14 Cr (FY 2025) | -37.0% | Delhi, India | |||
| Southend Pharma Pvt Ltdthis company | ₹21.94 Cr (FY 2025) | ₹24.84 Lakh | 1.1% | -25.0% | Kolkata, West Bengal, India | |
| Maypri Healthcare Private Limited | ₹21.86 Cr (FY 2024) | 15.0% | Noida, Uttar Pradesh, India | |||
| Vaxidrug Pharmaceuticals Private Limited | ₹21.79 Cr (FY 2024) | 26.0% | Coimbatore, Tamil Nadu, India |
To see the full peer comparison of Southend Pharma Pvt Ltd, buy the company report.
Auditor
Southend Pharma Pvt Ltd is audited by SANGHAI & ASSOCIATES for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SANGHAI & ASSOCIATES | FY 2022 | 314162E |
Shareholding
The shareholding of Southend Pharma Pvt Ltd is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Southend Pharma Pvt Ltd, buy the company report.
Charges & borrowings
Open charges
₹1.4 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 06 Feb 2021 | 100425893 | Hdfc Bank Limited | ₹1.4 Cr | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Southend Pharma Pvt Ltd are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Southend Pharma Pvt Ltd; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Southend Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 19AADCS6110P1Z0 | West Bengal | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Southend Pharma Pvt Ltd, buy the company report.
Recent activity
Southend Pharma Pvt Ltd has 20 board changes on record since 1989: 9 appointments and 11 cessations. The latest: Sandhya Lohia ceased to be Additional Director on 30 Nov 2021.
AGM
Southend Pharma Pvt Ltd last Annual general meeting of members was held on 27 Sep 2025 as per latest MCA records.
Filing
Southend Pharma Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kolkata.
Ceased
Sandhya Lohia ceased to be Additional Director.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 140.00 Lakh with Charge ID 100425893 was registered on 06 Feb 2021.
Appointed
Sandhya Lohia was appointed as Director.
Ceased
Ankit Lohia ceased to be Additional Director.
Ceased
Saket Lohia ceased to be Additional Director.
Appointed
Ankit Lohia was appointed as Director.
Appointed
Saket Lohia was appointed as Director.
Ceased
Manju Devi Dhanuka ceased to be Director.
Ceased
Madhu Devi Dhanuka ceased to be Director.
Ceased
Sulochana Devi Dhanuka ceased to be Director.
12 earlier events are in the company report.
Frequently asked questions
Southend Pharma is an active private limited company based in Kolkata, West Bengal, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 28 April 1989 (37+ years old) and is registered under CIN U51909WB1989PTC046785.
Southend Pharma has 9 current directors:
- Ajoy Kumar Lohia - Director
- Sanjoy Kumar Lohia - Director
- Surendra Dhanuka - Director
- Sandhya Lohia - Director
- Ankit Lohia - Director
- Saket Lohia - Director
- Radha Lohia - Director
- Jayant Dhanuka - Director
- Megha Dhanuka - Director
The latest financial statements of Southend Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 27 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Southend Pharma is 19AADCS6110P1Z0, registered in West Bengal.
The CIN (Corporate Identification Number) of Southend Pharma is U51909WB1989PTC046785. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Southend Pharma was incorporated on 28 April 1989, making it 37+ years old. It is registered with the Registrar of Companies, Kolkata.
The peers of Southend Pharma by revenue are Medibox Pharma Private Limited, Maypri Healthcare Private Limited, Vaxidrug Pharmaceuticals Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Sandhya Lohia ceased to be Additional Director on 30 Nov 2021. Sandhya Lohia was appointed as Director on 14 Feb 2020. Ankit Lohia ceased to be Additional Director on 30 Sep 2019. Southend Pharma has 20 board changes on record in total.
Yes, Southend Pharma is registered as a small enterprise under Udyam registration (number: UDYAM-WB-10-0010432).
The registered office of Southend Pharma is at Ground Floor Taranya House, 80B Swami Swarupananda Sarni, Kolkata, West Bengal, India – 700054.
Southend Pharma operates in the pharma industry, in the pharmaceutical retailers and distributors segment.